<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>p53 mutation is a common genetic change in human <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>, but the clinical significance is controversial </plain></SENT>
<SENT sid="1" pm="."><plain>We studied 68 patients and estimate the prevalence of <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> of cardia (IMC), <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> (BE), and p53 protein overexpression, and described molecular alterations of p53 gene exons 5 to 8 </plain></SENT>
<SENT sid="2" pm="."><plain>Immunohistochemical analysis showed positive p53 in 56.1-39.1% (IMC) and 60.9% (BE) </plain></SENT>
<SENT sid="3" pm="."><plain>Molecular analysis showed 36.6% altered cases in exon 5 and 9.8% in exon 7 </plain></SENT>
<SENT sid="4" pm="."><plain>In conclusion, p53 protein overexpression is common in IMC and BE </plain></SENT>
<SENT sid="5" pm="."><plain>The molecular alterations observed may be due to LOH, genomic instability or other unknown alteration </plain></SENT>
</text></document>